Expertise in
7
conditions

Dr. Bhupatkumar N. Mehta

Gastroenterology
Personal Physicians
5909 W 35th St, 
Cicero, IL 
Expertise in
7
conditions
Personal Physicians
5909 W 35th St, 
Cicero, IL 

Overview

Bhupatkumar Mehta is a Gastroenterologist practicing medicine in Cicero, Illinois.

Dr. Mehta is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Gastrointestinal Bleeding, Painful Swallowing, Swallowing Difficulty, Gastrostomy, and Gastrectomy.

He is actively involved in clinical research, participating in 5 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in IL

Hospital Affiliations

Loretto Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Personal Physicians
5909 W 35th St, Cicero, IL 60804

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
17
conditions
Dr. John E. Pandolfino
Gastroenterology
Expertise in
17
conditions
Dr. John E. Pandolfino
Gastroenterology
Referral may be required
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (9.3 miles away)
312-695-5620
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Pandolfino is a Gastroenterologist practicing medicine in Chicago, Illinois. Dr. Pandolfino is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Achalasia, Gastroesophageal Reflux Disease (GERD), Swallowing Difficulty, Endoscopy, and Colonoscopy. Dr. Pandolfino is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).

Expertise in
18
conditions
Dr. Peter J. Kahrilas
Gastroenterology
Expertise in
18
conditions
Dr. Peter J. Kahrilas
Gastroenterology
Referral may be required
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (9.3 miles away)
312-695-5620
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Peter Kahrilas is a Gastroenterologist practicing medicine in Chicago, Illinois. Dr. Kahrilas is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Achalasia, Gastroesophageal Reflux Disease (GERD), Heartburn, Endoscopy, and Gastrectomy. Dr. Kahrilas is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).

Expertise in
34
conditions
Dr. Scott J. Cotler
Gastroenterology
Expertise in
34
conditions
Dr. Scott J. Cotler
Gastroenterology
Referral may be required

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
 (4.0 miles away)
855-483-7362
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Scott Cotler is a Gastroenterologist practicing medicine in Maywood, Illinois. Dr. Cotler is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Liver Cancer, Liver Transplant, and Endoscopy. Dr. Cotler is currently accepting new patients.

Frequently Asked Questions about Dr. Bhupatkumar N. Mehta

How do I make an appointment with Dr. Bhupatkumar N. Mehta?

You can book an appointment with Dr. Bhupatkumar N. Mehta by calling their office at 708-652-2040. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bhupatkumar N. Mehta a top-rated expert for Gastrointestinal Bleeding?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bhupatkumar N. Mehta is classified as an Distinguished expert for Gastrointestinal Bleeding, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bhupatkumar N. Mehta specialize in?

While Dr. Bhupatkumar N. Mehta is a Gastroenterology, they have specific expertise in Gastrointestinal Bleeding, Painful Swallowing, and Swallowing Difficulty. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Bhupatkumar N. Mehta accept my insurance?

Dr. Bhupatkumar N. Mehta accepts most major insurance plans, including Aetna and Blue Shield of California. We recommend calling the office directly at 708-652-2040 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mehta's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile